US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist
  • 4.575
  • -0.125-2.66%
Trading Dec 19 13:30 ET
293.98MMarket Cap-4.62P/E (TTM)

Corvus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.32%-6.32M
-4.94%-5.48M
36.42%-5.16M
11.43%-23.94M
31.54%-5.17M
21.58%-5.43M
14.70%-5.22M
-26.26%-8.11M
26.40%-27.02M
-10.08%-7.55M
Net income from continuing operations
-570.28%-40.22M
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
Operating gains losses
3,776.07%33.53M
-196.50%-1.24M
-113.63%-236K
-47.07%5.28M
-69.58%1.4M
-68.32%865K
-19.55%1.28M
66.28%1.73M
106.64%9.98M
80.38%4.62M
Depreciation and amortization
-30.00%21K
-41.67%21K
-59.65%23K
-58.86%151K
-70.21%28K
-68.09%30K
-60.87%36K
-34.48%57K
-20.22%367K
1.08%94K
Change In working capital
121.90%138K
-70.85%-545K
109.72%219K
-354.53%-3.59M
86.42%-391K
-113.99%-630K
-95.71%-319K
-4,500.00%-2.25M
143.63%1.41M
-176.30%-2.88M
-Change in receivables
-218.18%-35K
-102.10%-9K
--0
793.83%562K
82.35%-15K
91.54%-11K
--429K
18.66%159K
84.02%-81K
63.20%-85K
-Change in prepaid assets
-913.64%-223K
-17.65%-280K
-28.81%84K
-101.38%-8K
-64.64%134K
-103.45%-22K
67.79%-238K
-61.18%118K
309.75%581K
-52.51%379K
-Change in payables and accrued expense
195.81%571K
65.17%-163K
107.41%185K
-558.88%-4.03M
85.70%-468K
-114.80%-596K
-178.66%-468K
-430.15%-2.5M
136.21%878K
-99.09%-3.27M
-Change in other current assets
-44.48%171K
-5.73%247K
7.58%284K
2.59%1.11M
-25.75%274K
32.19%308K
9.17%262K
10.92%264K
179.18%1.08M
35.16%369K
-Change in other current liabilities
-11.97%-346K
-11.84%-340K
-12.08%-334K
-17.30%-1.23M
-17.47%-316K
-17.05%-309K
-17.37%-304K
-17.32%-298K
-178.23%-1.05M
-13.03%-269K
Cash from discontinued investing activities
Operating cash flow
-16.32%-6.32M
-4.94%-5.48M
36.42%-5.16M
11.43%-23.94M
31.54%-5.17M
21.58%-5.43M
14.70%-5.22M
-26.26%-8.11M
26.40%-27.02M
-10.08%-7.55M
Investing cash flow
Cash flow from continuing investing activities
-122.17%-3.89M
-308.11%-17.5M
-100.15%-7K
166.77%15.54M
40.29%-2.32M
477.17%17.55M
-236.59%-4.29M
117.99%4.6M
-207.96%-23.28M
-94.20%-3.88M
Net PPE purchase and sale
--0
--0
--0
86.23%-34K
--0
--0
--0
---34K
-4,840.00%-247K
540.00%22K
Net investment purchase and sale
-122.17%-3.89M
-308.11%-17.5M
-100.15%-7K
167.63%15.58M
40.63%-2.32M
430.89%17.55M
-236.42%-4.29M
118.13%4.64M
-206.79%-23.03M
-95.79%-3.9M
Cash from discontinued investing activities
Investing cash flow
-122.17%-3.89M
-308.11%-17.5M
-100.15%-7K
166.77%15.54M
40.29%-2.32M
477.17%17.55M
-236.59%-4.29M
117.99%4.6M
-207.96%-23.28M
-94.20%-3.88M
Financing cash flow
Cash flow from continuing financing activities
-85.07%50K
304.07%30.37M
0
7.86M
0
335K
7.52M
4K
0
0
Net common stock issuance
--0
----
----
--7.84M
--0
--327K
----
----
--0
--0
Proceeds from stock option exercised by employees
525.00%50K
--13.97M
--0
--12K
--0
--8K
--0
--4K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-85.07%50K
304.07%30.37M
--0
--7.86M
--0
--335K
--7.52M
--4K
--0
--0
Net cash flow
Beginning cash position
93.80%14.84M
-22.77%7.46M
-4.10%12.62M
-79.26%13.16M
-18.23%20.11M
-73.11%7.66M
-69.31%9.65M
-79.26%13.16M
285.65%63.46M
-65.99%24.59M
Current changes in cash
-181.63%-10.16M
469.99%7.39M
-47.33%-5.16M
98.93%-539K
34.51%-7.49M
420.06%12.45M
33.09%-2M
89.05%-3.51M
-207.01%-50.3M
-29.33%-11.43M
End cash Position
-76.72%4.68M
93.80%14.84M
-22.77%7.46M
-4.10%12.62M
-4.10%12.62M
-18.23%20.11M
-73.11%7.66M
-69.31%9.65M
-79.26%13.16M
-79.26%13.16M
Free cash flow
-16.32%-6.32M
-4.94%-5.48M
36.69%-5.16M
12.18%-23.97M
31.54%-5.17M
24.46%-5.43M
14.75%-5.22M
-26.79%-8.15M
25.68%-27.29M
-10.00%-7.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.32%-6.32M-4.94%-5.48M36.42%-5.16M11.43%-23.94M31.54%-5.17M21.58%-5.43M14.70%-5.22M-26.26%-8.11M26.40%-27.02M-10.08%-7.55M
Net income from continuing operations -570.28%-40.22M34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M
Operating gains losses 3,776.07%33.53M-196.50%-1.24M-113.63%-236K-47.07%5.28M-69.58%1.4M-68.32%865K-19.55%1.28M66.28%1.73M106.64%9.98M80.38%4.62M
Depreciation and amortization -30.00%21K-41.67%21K-59.65%23K-58.86%151K-70.21%28K-68.09%30K-60.87%36K-34.48%57K-20.22%367K1.08%94K
Change In working capital 121.90%138K-70.85%-545K109.72%219K-354.53%-3.59M86.42%-391K-113.99%-630K-95.71%-319K-4,500.00%-2.25M143.63%1.41M-176.30%-2.88M
-Change in receivables -218.18%-35K-102.10%-9K--0793.83%562K82.35%-15K91.54%-11K--429K18.66%159K84.02%-81K63.20%-85K
-Change in prepaid assets -913.64%-223K-17.65%-280K-28.81%84K-101.38%-8K-64.64%134K-103.45%-22K67.79%-238K-61.18%118K309.75%581K-52.51%379K
-Change in payables and accrued expense 195.81%571K65.17%-163K107.41%185K-558.88%-4.03M85.70%-468K-114.80%-596K-178.66%-468K-430.15%-2.5M136.21%878K-99.09%-3.27M
-Change in other current assets -44.48%171K-5.73%247K7.58%284K2.59%1.11M-25.75%274K32.19%308K9.17%262K10.92%264K179.18%1.08M35.16%369K
-Change in other current liabilities -11.97%-346K-11.84%-340K-12.08%-334K-17.30%-1.23M-17.47%-316K-17.05%-309K-17.37%-304K-17.32%-298K-178.23%-1.05M-13.03%-269K
Cash from discontinued investing activities
Operating cash flow -16.32%-6.32M-4.94%-5.48M36.42%-5.16M11.43%-23.94M31.54%-5.17M21.58%-5.43M14.70%-5.22M-26.26%-8.11M26.40%-27.02M-10.08%-7.55M
Investing cash flow
Cash flow from continuing investing activities -122.17%-3.89M-308.11%-17.5M-100.15%-7K166.77%15.54M40.29%-2.32M477.17%17.55M-236.59%-4.29M117.99%4.6M-207.96%-23.28M-94.20%-3.88M
Net PPE purchase and sale --0--0--086.23%-34K--0--0--0---34K-4,840.00%-247K540.00%22K
Net investment purchase and sale -122.17%-3.89M-308.11%-17.5M-100.15%-7K167.63%15.58M40.63%-2.32M430.89%17.55M-236.42%-4.29M118.13%4.64M-206.79%-23.03M-95.79%-3.9M
Cash from discontinued investing activities
Investing cash flow -122.17%-3.89M-308.11%-17.5M-100.15%-7K166.77%15.54M40.29%-2.32M477.17%17.55M-236.59%-4.29M117.99%4.6M-207.96%-23.28M-94.20%-3.88M
Financing cash flow
Cash flow from continuing financing activities -85.07%50K304.07%30.37M07.86M0335K7.52M4K00
Net common stock issuance --0----------7.84M--0--327K----------0--0
Proceeds from stock option exercised by employees 525.00%50K--13.97M--0--12K--0--8K--0--4K--0--0
Cash from discontinued financing activities
Financing cash flow -85.07%50K304.07%30.37M--0--7.86M--0--335K--7.52M--4K--0--0
Net cash flow
Beginning cash position 93.80%14.84M-22.77%7.46M-4.10%12.62M-79.26%13.16M-18.23%20.11M-73.11%7.66M-69.31%9.65M-79.26%13.16M285.65%63.46M-65.99%24.59M
Current changes in cash -181.63%-10.16M469.99%7.39M-47.33%-5.16M98.93%-539K34.51%-7.49M420.06%12.45M33.09%-2M89.05%-3.51M-207.01%-50.3M-29.33%-11.43M
End cash Position -76.72%4.68M93.80%14.84M-22.77%7.46M-4.10%12.62M-4.10%12.62M-18.23%20.11M-73.11%7.66M-69.31%9.65M-79.26%13.16M-79.26%13.16M
Free cash flow -16.32%-6.32M-4.94%-5.48M36.69%-5.16M12.18%-23.97M31.54%-5.17M24.46%-5.43M14.75%-5.22M-26.79%-8.15M25.68%-27.29M-10.00%-7.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Heat List
US
Overall
Symbol
Price
% Chg

No Data